COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02244125
Brief Title: A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

First Submitted : September 8, 2014
First Submitted that Met QC Criteria : September 16, 2014
First Posted : September 18, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 5, 2018
Last Update Posted : April 6, 2018